Denali Therapeutics Inc.
161 Oyster Point Boulevard
South San Francisco
California
94080
United States
Website: http://www.denalitherapeutics.com/
Email: contact@dnli.com
132 articles about Denali Therapeutics Inc.
-
Denali plans to make a $100M IPO under the symbol DNLI.
-
What You Need to Know About Denali
1/12/2017
-
BioSpace is proud to present its NextGen “Class of 2017,” which is a list of 20 up-and-coming life science companies that launched no earlier than 2014.
-
Led by Former Genentech Execs, Denali Banks $130 Million, Initiates Trial and Announces a Handful of Partnerships
8/26/2016
-
f-Star Announces Collaborative Agreement With Denali For The Development Of A Multispecific Antibody Platform To Deliver Therapeutics Across The Blood-Brain Barrier
8/25/2016
-
Nine Bay Area Biotechs Vie to be the “Next Genentech”
5/26/2016
-
Inside the $50 Billion Biotech Sugar Daddy that Invested in Startups Like Denali, Juno
3/7/2016
-
Denali, Helmed by Former Genentech Execs, Takes Space in South San Francisco Site
1/20/2016
-
Denali Appoints Steve E. Krognes As Chief Financial Officer
9/8/2015
-
Denali Appoints Carole Ho, M.D., As Chief Medical Officer And Head Of Development
7/22/2015
-
Pfizer Board Member Jumps Ship to $217 Million Startup Denali
5/22/2015
-
Why Denali Raised A $217 Million Financing Round: Not Just "Because It Could"
5/21/2015